PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018
The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) project is a new project which will continue the activities initiated with Strengthening Pharmaceuticals Systems (SPS). The SIAPS's goal is to assure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes, by promoting and utilizing a systems strengthening approach consistent with the Global Health Initiative (GHI). The SIAPS project works at the central level to support the National Drug Regulatory Authority (NDRA) and Direcção Nacional de Assistência Médica/Departamento Farmácia Hospitalar (DNAM/DFH) on drug registration, pharmaceutical policy, formularies of Medicines, Standard Treatment Guidelines (STG), pharmacovigilance, HR strategies and pre-service curriculum, medicine selection, and support to the Technical Committee of Therapeutics and Pharmacy (CTTF). The project will support treatment scale up by strengthening ART and PMTCT pharmaceutical dispensing services. The primary focus of the SIAPS project will be on establishing sustainable systems for government and it is expected that the partner will work closely with the Ministry of Health to build ownership in strengthening the NDRA and DNAM/DFH to strengthen pharmacy services. The SIAPS Program Performance Monitoring Plan (PMP) will include a clearly defined Results Framework with indicators, baselines, and targets for output and impact level monitoring.USG plan to include central level mechanisms in the next expenditure analysis and costing exercises. There will no purchased/leased vehicles under this mechanism.
The Promoting the Quality of Medicines (PQM) project will train LNCQM staff for quality control of medicines, strengthen the National Laboratory for Quality Control of Medicines in all aspects to establish post market surveillance of medicines, and address quality-assurance related aspects of drug registration and licensing. PQM will technically support the development for executive project for the planned new National Laboratory for Quality Control of Medicines, to be funded under the Health Systems Strengthening program
PQM will also collaborate with the World Bank, the Global Fund to fight HIV/AIDS, Tuberculosis and Malaria, the Global Drug Facility, the Green Light Committee, and the DfID-funded Medicines Transparency Alliance (MeTA), among others, to expand the availability of high quality medicines and support system strengthening efforts directed toward improving the quality of medicines at the country level.
The PQM project will increase the capacity of Quality Control (QC) in Mozambique. The program of Medicines Quality Monitoring (MQM) using Minilab's basic tests, will be initiated in three regions of the country (Northern, Central, and Southern). This program will be done in collaboration with the Schools of Pharmacy, Instituto Superior de Ciências e Tecnologias de Moçambique (ISCTEM), UNILÚRIO and UNIZAMBEZE, through a Memorandum of Understanding (MoU). The PQM project will provide all technical assistance, Minilabs equipment, training, monitoring and evaluation, to ensure that the MQM program is working. This will allow the sampling and testing of at least 600 samples per year. The data from this program will be used for decision making to strengthen the QC capacities in the country.
There are no direct targets for this activity, although support to quality control and quality assurance will support overall care and treatment efforts to ensure availability of medicines with quality, effectiveness, and security for HIV, TB, Malaria and essential medicines.
